Clinical Trials Logo

Muscle Quality and NAD+ Content clinical trials

View clinical trials related to Muscle Quality and NAD+ Content.

Filter by:
  • None
  • Page 1

NCT ID: NCT04691986 Recruiting - Sarcopenia Clinical Trials

Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans

NR-VET
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Frailty is an age-associated clinical condition of poor physiological reserve that increases risks for falls, hospitalization and mortality. Nicotinamide adenine dinucleotide (NAD) is a critical co-factor needed for many cellular processes. The natural levels of NAD decline aging and this has been linked to physical performance decline in animals. Human trials have demonstrated that nicotinamide riboside (NR), a form of vitamin B3, is safe and effectively increases NAD+ levels. In animal studies, NR improves treadmill performance and muscle quality. Here the investigators propose a double-blind randomized control trial to assess the benefits of NR supplementation on human muscle function and physiology. The investigators anticipate the research findings will support the use of this nutritional supplement to improve the health of Veterans during aging.